Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T16:37:14.216Z.
Calculation as of: 2026-10-06T16:37:14.216Z.
Quote observation: 2026-10-06T16:35:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Generate Biomedicines, Inc.
Market Cap
$1.79B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.80B
Price/OCF Ratio
8.76
TTM Avg
22.76
3Y Avg
36.91
5Y Avg
32.83
Market Cap
$1.81B
Price/OCF Ratio
1208.89
TTM Avg
1290.99
3Y Avg
1290.99
5Y Avg
274.70
Market Cap
$1.82B
Price/OCF Ratio
21.89
TTM Avg
28.20
3Y Avg
39.35
5Y Avg
38.63
Market Cap
$1.82B
Price/OCF Ratio
N/A
TTM Avg
11.93
3Y Avg
11.93
5Y Avg
11.93
Market Cap
$1.76B
Price/OCF Ratio
6.82
TTM Avg
7.16
3Y Avg
10.90
5Y Avg
18.70
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.79B | N/A | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.80B | 8.76 | 22.76 | 36.91 | 32.83 |
| Absci Corporation (ABSI)vs › | $1.78B | N/A | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.81B | 1208.89 | 1290.99 | 1290.99 | 274.70 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 21.89 | 28.20 | 39.35 | 38.63 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | N/A | 11.93 | 11.93 | 11.93 |
| Azenta, Inc. (AZTA)vs › | $1.83B | 48.08 | 22.31 | 44.42 | 62.79 |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | 6.82 | 7.16 | 10.90 | 18.70 |
| Novavax, Inc. (NVAX)vs › | $1.84B | N/A | 135.88 | 59.40 | 80.74 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.85B | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
